Fiji Kava Ltd (FIJ)

Snapshot

FIJ's Principal Activity is the the Group is a medical kava company based in Australia and has established a nucleus farm near Levuka, on the island of Ovalau, Fiji. The Company sells its range of TGA and FDA compliant Fiji Kava products online and in Australia, Fiji, New Zealand, China and the United States. The Company plans to conduct human clinical trials to test the efficacy of Fiji Kavas products and specific kava cultivars, targeting a range of medical conditions.

Announcements

Corporate Overview

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date	Amount	Franking	Gross	Type	Payable
No dividends paid.

Show All

See Upcoming Dividends for all ASX companies.

Directors & Management

Name	Title	Since	Bio
Dr Anthony Noble	Chief Executive Officer,Managing Director	May 2021
Mr Jack Theseus Lowenstein	Non-Executive Director	Aug 2020	Mr Jack Theseus Lowenstein Non-Executive Director Mr Lowenstein is an experienced ASX listed company director, who also has corporate history in Fiji, where he was the co-founder of the country's first investment bank, Kontiki Capital Ltd. Mr Lowenstein is a director and shareholder in Kinetic and has invested in Fiji Kava both pre and post IPO. Mr Lowenstein is currently a director of ASX listed Morphic Ethical Equities Fund Ltd, which is managed by Morphic Asset Management, which he co-founded in 2012. Morphic Asset Management was acquired by Ellerston Capital in 2019. Prior to establishing Morphic, Mr Lowenstein spent 14 years with global stock investor Hunter Hall International, where he rose to become deputy chairman of the ASX listed parent company and a director of Hunter Hall Global Value Ltd. His career as a non-executive director began in 1997 when he joined the board of the iconic, but troubled ASX listed window furnishings company Kresta. In 1999, he joined the board of the embattled ASX listed global reinsurance company ReAC.
Mr Nicholas (NicK) Simms	Non-Executive Director	Sep 2019	Mr Nicholas (NicK) Simms Non-Executive Director Mr Simms has decades of experience as an FMCG sector and listed-company CEO roles, including with Bubs Australia, where he oversaw the transition of Bubs from a small private entity to an ASX300 company.
Dr Andrew Kelly	Non-Executive Chairman,Non-Executive Director	Dec 2018	Dr Andrew Kelly Non-Executive Chairman,Non-Executive Director Dr Kelly is Executive Director and Co-Founder of Bio Pacific Partners. He has experience across the Australian biotech scene. His 35-year career spans discovery science to success, focusing in equal measures on research, commercialisation and investment. Dr Kelly is currently Executive Director of Bio Pacific Investments Ltd (NZ) and Bio Pacific Partners Pty Ltd (Australia). He has previously been Director of Focus Genetics Ltd (NZ), Horizon Science Ltd (AU), Bio Pacific Ventures Ltd (NZ), Anzamune Ltd (NZ), CMP Therapeutics Ltd (UK), Wool Equities, Encoate Ltd (NZ), Cleveland Biosensors Ltd (AU), Inner Vision Ltd (NZ), Ultrafine Merino company Ltd (NZ), and Velvet Antler Research New Zealand Ltd (NZ). He is a member of the Due Diligence Committee.
Mr Zane Yoshida	Non-Executive Director	Dec 2018	Mr Zane Yoshida Non-Executive Director Mr Yoshida has experience over many decades in the kava industry. He is a Member of the National Codex Committee, Executive Committee Member of the Australia Fiji Business Council and the Fiji Kava Taskforce Committee, and Chair of the Fiji-based subsidiary of Fiji Kava, South Pacific Elixirs Ltd as well as join the Board of its US subsidiary,Fiji Kava Inc.
Mr Jay Richard Stephenson	Company Secretary	Feb 2018	Mr Jay Richard Stephenson Company Secretary Mr Stephenson has been part of business development for over 30 years, including approximately 26 years as Director, Chief Executive Officer, and Company Secretary of listed and unlisted entities in resources, manufacturing, wine, hotels and property. He has been part of business acquisitions, mergers, initial public offerings, capital raisings, and business restructuring, as well as managing all areas of finance for companies. Mr Stephenson is a Non-Executive Director of and Dragon Mountain Gold Limited since July 2011, Strategic Minerals Corporation NL since 2009, Stonehorse Energy Limited since July 2011, and a former Non-Executive Director of Doray Mining Limited (August 2009 to April 2019), Chairman, Non-Executive Director of Auctus Alternative Investments Limited (February 2011 - March 2019), Drake Resources Limited (2005 to December 2017) and Blina Minerals Limited (October 2016 to April 2019). He is a member of the Due Diligence Committee.

Show All

Director Transactions

Date	Director	Type	Amount	Price	Value	Notes
30/06/21	Zane Yoshida	Transfer	1,700,000	$0.10	$170,000	Off-market transfer
23/06/21	Zane Yoshida	Sell	+50,000	$1.00	($49,999)	On-market trade
29/12/20	Zane Yoshida	Buy	+750,000	$0.10	$75,000	Off-market trade
22/12/20	Nicholas (NicK) Simms	Issued	1,000,000	$0.11	$110,000	Issue of options
22/12/20	Jack Lowenstein	Issued	750,000	$0.11	$82,500	Issue of options
05/08/20	Nicholas (NicK) Simms	Buy	+441,176	$0.057	$25,000	Conversion of convertible notes
05/08/20	Nicholas (NicK) Simms	Exercise	1	$25,000.00	$25,000	Conversion of convertible notes
05/08/20	Nicholas (NicK) Simms	Issued	1	$0.00	$0	Issue of securities
20/03/20	Andrew Kelly	Buy	+43,112	$0.035	$1,508	On-market trade
12/03/20	Zane Yoshida	Transfer	20,000	$0.06	$1,200	Off-market transfer
12/03/20	Zane Yoshida	Transfer	20,000	$0.06	$1,200	Off-market transfer
12/03/20	Zane Yoshida	Buy	+45,000	$0.066	$2,970	On-market trade
12/03/20	Zane Yoshida	Buy	+45,000	$0.066	$2,970	On-market trade
12/03/20	Zane Yoshida	Transfer	20,000	$0.06	$1,200	Off-market transfer
12/03/20	Zane Yoshida	Transfer	20,000	$0.06	$1,200	Off-market transfer
10/03/20	Zane Yoshida	Buy	+20,000	$0.075	$1,500	On-market trade
10/03/20	Zane Yoshida	Buy	+20,000	$0.075	$1,500	On-market trade
09/03/20	Andrew Kelly	Buy	+400,000	$0.076	$30,400	On-market trade
09/03/20	Andrew Kelly	Buy	+400,000	$0.076	$30,400	On-market trade
27/12/19	Andrew Kelly	Buy	+244,918	$0.075	$18,369	On-market trade
27/12/19	Zane Yoshida	Buy	+15,000	$0.089	$1,335	On-market trade
27/12/19	Nicholas Simms	Issued	750,000	$0.075	$56,250	Issue of securities
29/03/19	Andrew Kelly	Buy	+74,000	$0.086	$6,371	On-market trade
19/03/19	Andrew Kelly	Buy	+10,001	$0.086	$860	On-market trade
12/03/19	Zane Yoshida	Buy	+19,755	$0.119	$2,346	On-market trade
11/03/19	Andrew Kelly	Buy	+29,245	$0.096	$2,812	On-market trade

Show All

Director Interests

Director	Last Notice	Direct Shares	Indirect Shares	Options	Convertibles
Zane Yoshida	30/06/2021	51,714	12,965,314	N/A	N/A
Nicholas (NicK) Simms	22/12/2020	0	441,176	1,750,000	0
Jack Lowenstein	22/12/2020	410,000	2,958,189	1,450,000	N/A
Jay Stephenson	11/08/2020	0	N/A	N/A	N/A
Andrew Kelly	30/06/2020	801,276	N/A	750,000	N/A
Anthony Noble	N/A	N/A	N/A	N/A	N/A

Show All

Top 20 Shareholders

About the Data

Name	Shares	Capital
N/A	0	0.00%

Show All

Shareholder Distribution

As reported in the most recent Annual Report.

The most recent Annual Report didn't contain Shareholder Distribution data.

Substantial Shareholders

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Share Price History

Date	Close	Change	%Chg	Open	High	Low	Volume	Turnover

Full Month

Historical Data

Year	Closing Price	Last Trade
2020	$0.073	30 June
2019	$0.08	28 June

FIJ Historical Price Data (CSV)

Up to 20 years of EOD share price history

Sign up to Download

You must be logged in to access this feature. Please sign up for free or login.